Skip to main content
Contact Us
Subscribe
E-Edition
74°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Natus Medical Inc
(NQ:
NTUS
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jul 20, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
32.41 (1)
Ask (Size)
33.76 (1)
Prev. Close
32.96
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
34,130,686
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Route 92 Medical Announces Appointment of Jonathan Kennedy as Chief Financial Officer
September 18, 2023
From
Route 92 Medical, Inc.
Via
GlobeNewswire
Novanta Shares Pop On Inclusion Into S&P MidCap 400
July 22, 2022
Via
Benzinga
Performance
More News
Read More
NATUS MEDICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Natus Medical Incorporated - NTUS
May 17, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
NATUS MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Natus Medical Incorporated - NTUS
May 05, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
68 Biggest Movers From Yesterday
April 19, 2022
Via
Benzinga
Mid-Afternoon Market Update: Crude Oil Rises Over 1%; Nektar Therapeutics Shares Slide
April 18, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 18, 2022
Via
Benzinga
Dow Moves Lower As Wall Street Gears Up For Earnings
April 18, 2022
Via
Talk Markets
Mid-Day Market Update: U.S. Stocks Turn Lower; Bank of America Earnings Top Views
April 18, 2022
Via
Benzinga
34 Stocks Moving In Monday's Mid-Day Session
April 18, 2022
Via
Benzinga
Mid-Morning Market Update: Markets Open Higher; Dow Gains 100 Points
April 18, 2022
Via
Benzinga
NTUS Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Natus Medical Incorporated Is Fair to Shareholders
April 18, 2022
From
Halper Sadeh LLP
Via
Business Wire
Benzinga's Daily Brief On Trending Tickers For April 18, 2022: Casa Systems, Twitter, DiDi Global, And More
April 18, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 18, 2022
Via
Benzinga
Neurodiagnostic Focused Natus Medical Goes Private In $1.2B Deal
April 18, 2022
Via
Benzinga
Natus Medical: Q4 Earnings Insights
February 24, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
February 07, 2022
Via
Benzinga
The Daily Biotech Pulse: Illunina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In
January 11, 2022
Via
Benzinga
Natus Medical Inc (NTUS) Q3 2021 Earnings Call Transcript
November 05, 2021
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Return on Capital Employed Overview: Natus Medical
August 20, 2021
Via
Benzinga
Natus Medical Inc (NTUS) Q2 2021 Earnings Call Transcript
August 06, 2021
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs
June 18, 2021
Via
Benzinga
Exposures
Product Safety
Stocks That Hit 52-Week Highs On Thursday
June 17, 2021
Via
Benzinga
The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme
June 17, 2021
Via
Benzinga
Exposures
COVID-19
Top 10 Reddit Stocks As Frenzy Hints At Life Beyond WallStreetBets
June 10, 2021
Via
Investor's Business Daily
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.